Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The counter-irritant effect refers to a pain relief strategy in which irritation or mild inflammation is induced at a superficial site (usually the skin) with the aim of alleviating discomfort or inflammation in underlying muscles, joints, or areas distant to the site of application[4][2]. Common counterirritants include capsaicin, menthol, methyl salicylate, and camphor, which are ingredients in topical pain-relieving creams and patches. The mechanism primarily involves stimulation of thermosensitive ion channels (notably TRPV1, TRPA1, TRPM8), leading to both initial excitement and eventual desensitization of sensory neurons, thereby reducing the transmission of pain signals[2][5][6]. This approach does not target a specific molecular entity but acts by modulating neuronal pain pathways and central pain processing.
Induction of mild local irritation or inflammation. Activation and subsequent desensitization of sensory nerve endings, particularly via transient receptor potential (TRP) channels (such as TRPV1 for capsaicin, TRPM8 for menthol). Altered pain signaling through counterstimulation, leading to reduced perception of deeper or referred pain.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Counter-irritant effect.